In view of the recent abuse situation of etomidate, the main active ingredient of the “space oil drug”, the Security Bureau announced today that etomidate and its three analogues will be listed in the Gazette as dangerous drugs starting this Friday.

The move aims to enhance deterrence and enable effective law enforcement actions against the “space oil drug”, the bureau said in a press release.

It explained that the Dangerous Drugs Ordinance (Amendment of First Schedule) Order 2025 Order will add six substances - butonitazene, bromazolam, etomidate, metomidate, propoxate and isopropoxate to the First Schedule to the Dangerous Drugs Ordinance. Among them, metomidate, propoxate and isopropoxate are analogues of etomidate.

The order will take effect upon gazettal on Friday.

Under the Dangerous Drugs Ordinance, trafficking and illicit manufacturing of these substances are liable to a maximum penalty of life imprisonment and a fine of $5 million; possession and consumption of these substances will be subject to a maximum penalty of seven years’ imprisonment and a fine of $1 million.

To tie in with the legislative work, the Government will launch on Friday a new TV Announcement in the Public Interest titled Don’t fall into “space oil drug” traps! and will continue placing both online and offline advertisements to promote the relevant message.

Furthermore, as young people are the target of “space oil drug” sellers, the Security Bureau’s Narcotics Division and the Education Bureau will jointly launch an “anti-space oil drug week” in schools at the end of the month, during which talks, anti-drug video broadcasts and drama shows will be staged.

The Dangerous Drugs Ordinance (Amendment of First Schedule) Order 2025 as well as the Control of Chemicals Ordinance (Amendment of Schedule 2) Order 2025, both to be gazetted on Friday, are subject to the Legislative Council’s negative vetting procedure.